Gumansing, Eleza L.

HRN: 25-54-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/23/2024
07/29/2024
IV
4.5 Gms
Q8H
Pleural Effusion CAP HR
Waiting Final Action 
07/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/31/2024
08/14/2024
IV
2.25gms
Q8
CAP HR
Waiting Final Action 
08/04/2024
MUPIROCIN 2%, 15G (TUBE)
08/04/2024
08/10/2024
TOPICAL
2%
Q12
Decubitus Ulcer
Waiting Final Action 
08/08/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/08/2024
08/14/2024
TOPICAL
1%
Bid
Decubitus Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: